Identification and characterization of interferon signaling-related microRNAs in occult hepatitis B virus infection

[1]  Lanjuan Li,et al.  Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update) , 2017, Journal of clinical and translational hepatology.

[2]  Yu-ming Shen,et al.  Dynamic correlation between induction of the expression of heme oxygenase-1 and hepatitis B viral replication. , 2015, Molecular medicine reports.

[3]  J. Qian,et al.  Down-regulation of suppressor of cytokine signaling 3 by miR-122 enhances interferon-mediated suppression of hepatitis B virus. , 2015, Antiviral research.

[4]  M. Tao,et al.  MicroRNA-130a can inhibit hepatitis B virus replication via targeting PGC1α and PPARγ , 2015, RNA.

[5]  S. Batra,et al.  MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers. , 2014, Current pharmaceutical design.

[6]  Youwen Tan,et al.  A Serum MicroRNA Panel as Potential Biomarkers for Hepatocellular Carcinoma Related with Hepatitis B Virus , 2014, PloS one.

[7]  L. Velloso,et al.  Maternal high-fat diet consumption modulates hepatic lipid metabolism and microRNA-122 (miR-122) and microRNA-370 (miR-370) expression in offspring , 2014, British Journal of Nutrition.

[8]  B. Liu,et al.  MicroRNA‐130a inhibits HCV replication by restoring the innate immune response , 2014, Journal of viral hepatitis.

[9]  R. Robitaille,et al.  Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: promises and challenges. , 2013, Clinical biochemistry.

[10]  Jianguo Wu,et al.  HCV-Induced miR-21 Contributes to Evasion of Host Immune System by Targeting MyD88 and IRAK1 , 2013, PLoS pathogens.

[11]  A. Berger,et al.  Serum microRNA‐122 levels in different groups of patients with chronic hepatitis B virus infection , 2012, Journal of viral hepatitis.

[12]  Leina Ma,et al.  MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest. , 2011, Cancer letters.

[13]  Rong-hua Liu,et al.  [Effects of miR-122 on expression of hepatitis B virus proteins]. , 2011, Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences.

[14]  I. Hung,et al.  Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma , 2011, Hepatology.

[15]  M. David,et al.  Interferons and microRNAs. , 2010, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[16]  I. Kovalszky,et al.  [Alterations in microRNA expression patterns in liver diseases]. , 2010, Orvosi hetilap.

[17]  Lipeng Qiu,et al.  miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV. , 2010, Biochemical and biophysical research communications.

[18]  A. Zanetti,et al.  A 2010 update on occult hepatitis B infection. , 2010, Pathologie-biologie.

[19]  F. Belardelli,et al.  Recent advances on the immunomodulatory effects of IFN-α: Implications for cancer immunotherapy and autoimmunity , 2010, Autoimmunity.

[20]  Yoshiyuki Suzuki,et al.  Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non‐B, non‐C liver cirrhosis: a cohort study , 2009, Journal of viral hepatitis.

[21]  F. Zoulim,et al.  Altered expression profiles of microRNAs in a stable hepatitis B virus-expressing cell line. , 2009, Chinese medical journal.

[22]  C. Burge,et al.  Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.

[23]  T. Ochiya,et al.  microRNAs and Hepatitis B. , 2015, Advances in experimental medicine and biology.

[24]  G. Cheng,et al.  Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy. , 2015, Advanced drug delivery reviews.

[25]  Michael D. Wilson,et al.  A feedback loop between the liver-enriched transcription factor network and miR-122 controls hepatocyte differentiation. , 2012, Gastroenterology.